Abnormal activation of the phosphatidylinositol 3′-kinase/protein kinase B PI3K-AKT pathway is one of the critical factors for cancer cell survival and it is frequently dysregulated, leading to chemotherapy-resistant cancer cells [61,62]. This evidence concerns the gene AKT1 and cancer.